|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
37,543,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Co.'s solution, which is comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. Co.'s solution is designed to address the need for for patients with severe emphysema, providing bronchoscopic lung volume reduction without surgery and its associated risks.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
14,245 |
14,245 |
14,245 |
21,383 |
Total Buy Value |
$97,436 |
$97,436 |
$97,436 |
$135,677 |
Total People Bought |
1 |
1 |
1 |
3 |
Total Buy Transactions |
1 |
1 |
1 |
3 |
Total Shares Sold |
31,535 |
43,675 |
121,738 |
186,112 |
Total Sell Value |
$238,390 |
$325,682 |
$1,251,053 |
$1,940,593 |
Total People Sold |
3 |
3 |
4 |
5 |
Total Sell Transactions |
4 |
8 |
26 |
44 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rose Geoffrey Beran |
Chief Commercial Officer |
|
2023-03-01 |
4 |
S |
$11.03 |
$13,302 |
D/D |
(1,206) |
180,993 |
|
- |
|
Lehman David Aaron |
General Counsel |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
118,300 |
161,196 |
|
- |
|
Lehman David Aaron |
General Counsel |
|
2023-03-01 |
4 |
S |
$11.03 |
$13,942 |
D/D |
(1,264) |
42,896 |
|
- |
|
Sung Derrick |
Chief Financial Officer |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
138,000 |
399,482 |
|
- |
|
Sung Derrick |
Chief Financial Officer |
|
2023-03-01 |
4 |
S |
$11.03 |
$13,942 |
D/D |
(1,264) |
261,482 |
|
- |
|
Sung Derrick |
Chief Financial Officer |
|
2022-12-01 |
4 |
S |
$5.93 |
$6,339 |
D/D |
(1,069) |
262,746 |
|
- |
|
Rose Geoffrey Beran |
Chief Commercial Officer |
|
2022-12-01 |
4 |
S |
$5.93 |
$6,256 |
D/D |
(1,055) |
181,037 |
|
- |
|
French Glendon E. Iii |
President and CEO |
|
2022-12-01 |
4 |
S |
$5.93 |
$21,532 |
D/D |
(3,631) |
1,034,313 |
|
- |
|
Lehman David Aaron |
General Counsel |
|
2022-12-01 |
4 |
S |
$5.93 |
$6,339 |
D/D |
(1,069) |
44,160 |
|
- |
|
Lynch Alissa Hsu |
Director |
|
2022-11-29 |
4 |
B |
$5.51 |
$9,367 |
D/D |
1,700 |
11,910 |
2.39 |
- |
|
Sung Derrick |
Chief Financial Officer |
|
2022-11-14 |
4 |
OE |
$2.20 |
$22,000 |
D/D |
10,000 |
263,815 |
|
- |
|
French Glendon E. Iii |
President and CEO |
|
2022-11-14 |
4 |
OE |
$2.20 |
$22,000 |
D/D |
10,000 |
1,037,944 |
|
- |
|
Ferrari Richard M |
Director |
|
2022-11-08 |
4 |
B |
$5.29 |
$28,874 |
D/D |
5,438 |
30,035 |
2.39 |
- |
|
French Glendon E. Iii |
President and CEO |
|
2022-09-15 |
4 |
AS |
$20.00 |
$500,000 |
D/D |
(25,000) |
1,027,944 |
|
- |
|
Lehman David Aaron |
General Counsel |
|
2022-09-01 |
4 |
S |
$17.88 |
$19,350 |
D/D |
(1,082) |
45,229 |
|
- |
|
Rose Geoffrey Beran |
Chief Commercial Officer |
|
2022-09-01 |
4 |
S |
$17.87 |
$18,372 |
D/D |
(1,027) |
182,092 |
|
- |
|
French Glendon E. Iii |
President and CEO |
|
2022-09-01 |
4 |
S |
$17.87 |
$52,538 |
D/D |
(2,940) |
1,052,944 |
|
- |
|
Sung Derrick |
Chief Financial Officer |
|
2022-09-01 |
4 |
S |
$17.87 |
$19,335 |
D/D |
(1,082) |
253,815 |
|
- |
|
French Glendon E. Iii |
President and CEO |
|
2022-08-18 |
4 |
AS |
$20.59 |
$1,029,500 |
D/D |
(50,000) |
1,055,884 |
|
- |
|
Ferrari Richard M |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
24,597 |
|
- |
|
Sung Derrick |
Chief Financial Officer |
|
2022-06-01 |
4 |
S |
$18.05 |
$19,223 |
D/D |
(1,065) |
254,897 |
|
- |
|
Lynch Alissa Hsu |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
10,210 |
|
- |
|
Melenikiotou Georgia |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
34,725 |
|
- |
|
Mead Dana G Jr |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
34,725 |
|
- |
|
Burns Thomas William |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
8,410 |
|
- |
|
168 Records found
|
|
Page 3 of 7 |
|
|